Apogee Shares Are Up Nearly 100% in 12 Months, and This $62 Million Purchase Indicates Continued Conviction
On February 17, 2026, Perceptive Advisors revealed a purchase of 978,662 shares of Apogee Therapeutics (NASDAQ: APGE)with an estimated transaction value of $61.64 million based on the quarterly average price. According to a February 17, 2026 SEC filing, Perceptive Advisors increased its stake in Apogee Therapeutics (NASDAQ: APGE) for 978,662 shares. The estimated value of…